Pharma major Sun Pharmaceutical Industries Ltd. on Tuesday said it along with one of its subsidiaries have reached an agreement with Celgene Corporation (Celgene) to resolve a patent litigation.
Lenalidomide drug is used to treat various types of cancers by slowing or stopping the growth of aberrant cells
Celgene is interested in Impact Biomedicines' fedratinib that has shown promise as a potential treatment for a type of blood cancer